TSX:ONC 0.78 CAD +0.02 +2.63% Volume: 46,483 August 31, 2015
NASDAQ:ONCY 0.60 USD +0.02 +3.1% Volume: 277,852 August 31, 2015

Financials

Annual Reports

Financial Reports

Fiscal Year First Quarter Second Quarter Third Quarter Information Circular Financials & MD&A Annual Report

Tax Information

PASSIVE FOREIGN INVESTMENT COMPANY
PFIC Annual Information Statement (2014 Tax Year) PFIC Annual Information Statement (2013 Tax Year) PFIC Annual Information Statement (2012 Tax Year) PFIC Annual Information Statement (2011 Tax Year) PFIC Annual Information Statement (2010 Tax Year)

DISCLAIMER: THIS INFORMATION IS PROVIDED IN ORDER TO ASSIST SHAREHOLDERS IN MAKING CALCULATIONS AND DOES NOT CONSTITUTE TAX ADVICE. SHAREHOLDERS ARE ADVISED TO CONSULT THEIR OWN TAX ADVISORS CONCERNING THE OVERALL TAX CONSEQUENCES OF THE OWNERSHIP OF COMMON SHARES ARISING IN THEIR OWN PARTICULAR SITUATIONS UNDER UNITED STATES FEDERAL, STATE, LOCAL OR FOREIGN LAW.

Filings

SEDAR View our filings as a publicly listed company in Canada (TSX).

EDGAR Our SEC filings as a publicly listed company in the United States (NASDAQ).

Analyst Coverage

Find out which analysts and institutions provide coverage of Oncolytics.

View Analyst Coverage

Latest News

August 27, 2015 Oncolytics Biotech® Inc. Collaborators to Present Survival Data from REO 016 Study in Non-Small Cell Lung Cancer
August 26, 2015 Oncolytics Biotech® Inc. Announces Completion of Enrollment in Randomized Phase II Non-Small Cell Lung Cancer Study
August 12, 2015 MEDIA ADVISORY - Oncolytics Biotech® Inc. to Participate in the 35th Annual Canaccord Genuity Growth Conference
Sign up to receive e-mail updates *